永安药业：11月11日召开董事会会议

Group 1 - The core point of the article is that Yong'an Pharmaceutical announced a temporary board meeting to discuss a merger involving its subsidiary, which will lead to changes in investment targets and related transactions [1] - For the first half of 2025, Yong'an Pharmaceutical's revenue composition is as follows: pharmaceutical manufacturing accounts for 64.14%, health food accounts for 24.67%, chemical manufacturing accounts for 10.88%, and other businesses account for 0.32% [1] - As of the report, Yong'an Pharmaceutical has a market capitalization of 5.3 billion yuan [1] Group 2 - Prior to the arrest of the chairman of Peking University Pharmaceutical, police had investigated the group's factory premises, indicating potential issues within the company [1] - Internal sources suggest that the group's assets have been disposed of by the chairman, with significant amounts of funds unaccounted for [1]